Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models? - Université Claude Bernard Lyon 1 Accéder directement au contenu
Article Dans Une Revue Cancer and Metastasis Reviews Année : 2016

Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?

Résumé

In the era of modern radiation therapy, the compromise between the reductions in deterministic radiation-induced toxicities through highly conformal devices may be impacting the stochastic risk of second malignancies. We reviewed the clinical literature and evolving theoretical models evaluating the impact of intensity-modulated radiation therapy (IMRT) on the risk of second cancers, as a consequence of the increase in volumes of normal tissues receiving low doses. The risk increase (if any) is not as high as theoretical models have predicted in adults. Moreover, the increase in out-of-field radiation doses with IMRT could be counterbalanced by the decrease in volumes receiving high doses. Clinical studies with short follow-up have not corroborated the hypothesis that IMRT would drastically increase the incidence of second cancers. In children, the risk of radiation-induced carcinogenesis increases from low doses and consequently the relative risk of second cancers after IMRT could be higher than in adults, justifying current developments of proton therapy with priority given to this population. Although only longer follow-up will allow a true assessment of the real impact of these modern techniques on radiation-induced carcinogenesis, a comprehensive risk-adapted strategy will help minimize the probability of second cancers.
Fichier non déposé

Dates et versions

hal-01404955 , version 1 (29-11-2016)

Identifiants

Citer

Cyrus Chargari, Karyn A. Goodman, Ibrahima Diallo, Jean-Baptiste Guy, Chloé Rancoule, et al.. Risk of second cancers in the era of modern radiation therapy: does the risk/benefit analysis overcome theoretical models?. Cancer and Metastasis Reviews, 2016, 35 (2), pp.277-288. ⟨10.1007/s10555-016-9616-2⟩. ⟨hal-01404955⟩
100 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More